首页> 外文学位 >Assembly and trafficking of nmda receptors: a biochemical approach.
【24h】

Assembly and trafficking of nmda receptors: a biochemical approach.

机译:nmda受体的组装和运输:一种生物化学方法。

获取原文
获取原文并翻译 | 示例

摘要

The N-methyl-D-aspartate (NMDA) receptor is a subtype of the excitatory, ionotropic L- glutamate neurotransmitter receptor family. Functional NMDA receptors are composed of the obligatory NR1 subunits together with NR2 subunits. The NMDA receptor subunits are encoded by seven genes: NR1, NR2A-NR2D, NR3A and NR3B. The NR1 subunit gene undergoes alternative splicing to yield eight splice variants: NR1-1a, NR1-1b- NR1-4a., NR1-4b. NMDA receptors are targeted to dendritic spines of neurones where they associate with proteins of the post-synaptic density such as the scaffolding protein, post-synaptic density 95 (PSD-95). The aim of this thesis was to study the assembly and trafficking of NMDA receptors. This investigation was initiated by observing that insertion of the c-Myc epitope at position 81 of the NR1-2a subunit (NRl-2ac-Myc) did not result in NMDA receptor-mediated cell cytotoxicity following co-expression with NR2A in human embryonic kidney (HEK) 293 cells. NR1-2a/NR2 and NR1-2ac-Myc/NR2 were transiently expressed in HEK 293 cells and analysed by one and two dimensional immunoblotting, cell surface ELISAs, [3H]MDL105,519 and [3H]MK801 radioligand binding activities and co-immunoprecipitation. NR1-2ac-Myc/NR2 behaved as wild-type except that mutant receptors were not expressed on the cell surface and m immunoblots only an NR1 Mr 116 kDa species was detected compared to Mr 115 and a 226 kDa species for wild-type. Two-dimensional electrophoresis of the NR1 Mr 226 kDa species revealed that it represented disulphide-1 inked NR1 subunits, suggesting that insertion of the c-Myc tag may interfere with NR1-NR1 disulphide-linked dimer formation. To investigate this further, cysteines 22, 79 and 308 of the NRl-2a subunit were mutated to alanine, co-expressed with NR2 m HEK 293 cells and analysed as above. Receptors containing the C79A and C308A mutations in the NR1-2a subunit, showed impaired cell surface expression and NR1-2ac79A/NR2A lacked the NR1 Mr 226 kDa species. These results reveal that NR1-NR1 inter-subunit disulphide bond formation involving cysteine 79 is requisite for the efficient trafficking of NR1/NR2 NMDA receptors to the cell surface. The synaptic targeting of NMDA receptors is mediated by PSD-95. Recently, an alternative splice form of PSD-95 was identified, termed PSD-95beta. Co-immunoprecipitation experiments demonstrated that PSD-95beta associates with NR1-1a/NR2A receptors in HEK 293 cells. This association resulted in an ˜ 4-fold increase in the expression levels of the NR2A subunit relative to NR1-1a/NR2A receptors expressed alone. Collectively, these results offer new grounds towards understanding the complicated exocytotic machinery involved in the assembly of NMDA receptors.
机译:N-甲基-D-天冬氨酸(NMDA)受体是兴奋性,离子型L-谷氨酸神经递质受体家族的亚型。功能性NMDA受体由强制性的NR1亚基和NR2亚基组成。 NMDA受体亚基由七个基因编码:NR1,NR2A-NR2D,NR3A和NR3B。对NR1亚基基因进行选择性剪接以产生八个剪接变体:NR1-1a,NR1-1b-NR1-4a,NR1-4b。 NMDA受体靶向神经元的树突棘,它们与突触后密度的蛋白质(例如支架蛋白,突触后密度95(PSD-95))相关。本文的目的是研究NMDA受体的组装和运输。通过观察在人类胚胎肾脏中与NR2A共表达后,在NR1-2a亚基(NR1-2ac-Myc)81位插入c-Myc表位不会导致NMDA受体介导的细胞毒性,从而启动了这项研究。 (HEK)293细胞。 NR1-2a / NR2和NR1-2ac-Myc / NR2在HEK 293细胞中瞬时表达,并通过一维和二维免疫印迹,细胞表面ELISA,[3H] MDL105,519和[3H] MK801放射性配体结合活性以及免疫沉淀。 NR1-2ac-Myc / NR2表现为野生型,不同之处在于突变受体未在细胞表面表达,并且在免疫印迹中仅检测到NR1 Mr 116 kDa物种,而Mr 115和226 kDa物种为野生型。 NR1 Mr 226 kDa物种的二维电泳显示,它代表二硫键1着墨的NR1亚基,表明c-Myc标签的插入可能会干扰NR1-NR1二硫键连接的二聚体的形成。为了进一步研究,将NR1-2a亚基的半胱氨酸22、79和308突变为丙氨酸,与NR2m HEK 293细胞共表达并如上所述进行分析。 NR1-2a亚基中含有C79A和C308A突变的受体显示受损的细胞表面表达,NR1-2ac79A / NR2A缺少NR1 Mr 226 kDa物种。这些结果表明,涉及半胱氨酸79的NR1-NR1亚单位间二硫键形成是将NR1 / NR2 NMDA受体有效转运至细胞表面所必需的。 PSD-95介导NMDA受体的突触靶向。最近,确定了另一种PSD-95的剪接形式,称为PSD-95beta。免疫共沉淀实验表明,PSD-95beta与HEK 293细胞中的NR1-1a / NR2A受体相关。相对于单独表达的NR1-1a / NR2A受体,该缔合导致NR2A亚基的表达水平增加约4倍。总的来说,这些结果为理解NMDA受体组装中涉及的复杂的胞吐机制提供了新的依据。

著录项

  • 作者

    Papadakis, Michalis.;

  • 作者单位

    University of London, University College London (United Kingdom).;

  • 授予单位 University of London, University College London (United Kingdom).;
  • 学科 Pharmaceutical sciences.;Chemistry.
  • 学位 Ph.D.
  • 年度 2004
  • 页码 254 p.
  • 总页数 254
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号